Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;32(4):521-528.
doi: 10.1016/j.echo.2018.12.009. Epub 2019 Feb 28.

Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy

Anthony F Yu  1 , Alice Y Ho  2 , Lior Z Braunstein  3 , Maria E Thor  4 , Katherine Lee Chuy  5 , Anne Eaton  6 , Elton Mara  5 , Oren Cahlon  3 , Chau T Dang  7 , Kevin C Oeffinger  8 , Richard M Steingart  9 , Jennifer E Liu  9
Affiliations

Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy

Anthony F Yu et al. J Am Soc Echocardiogr. 2019 Apr.

Abstract

Background: Radiation therapy (RT)-induced cardiotoxicity is among the concerning sequelae of breast cancer (BCA) treatment, particularly in HER2-positive BCA patients who receive anthracyclines and trastuzumab-based therapy. The aim of this study was to assess for early RT-induced changes in echocardiographic and circulating biomarkers of left ventricular (LV) function and evaluate their association with radiation dose to the heart among patients with HER2-positive BCA treated with contemporary RT.

Methods: A total of 47 women with HER2-positive BCA who were treated with an anthracycline, trastuzumab, and RT to the breast and/or chest wall ± regional lymph nodes were included in this study. Two-dimensional echocardiography with speckle-tracking imaging was performed at baseline (prechemotherapy), prior to and after RT (pre-RT and post-RT), and 6 months post-RT. High-sensitivity troponin I (hsTnI) was measured pre-RT and post-RT. Associations between mean heart dose (MHD) and changes in LV function after RT were examined in multivariable linear regression models.

Results: The MHD was 1.8 ± 1.5 Gy for patients receiving left-sided RT (n = 26) and 1.1 ± 1.3 Gy for patients receiving right-sided RT (n = 21). Pre-RT, post-RT, and 6-month post-RT echocardiograms were performed at median (interquartile range) of 49 days (27, 77) before and 54 days (25, 78) and 195 days (175, 226) after RT, respectively. Compared with pre-RT, a minimal decrease in LV ejection fraction was observed post-RT (61% ± 7% vs 59% ± 8%; P = .003) without any significant change in global longitudinal, circumferential, or radial strain or diastolic indices at the post-RT timepoint. Median (interquartile range) concentrations of hsTnI decreased from 5.7 pg/mL (3.0, 8.7) pre-RT to 3.7 pg/mL (2.0, 5.9) post-RT. There was no significant change in systolic or diastolic indices of LV function at 6 months post-RT compared with pre-RT. MHD was not associated with changes in echocardiographic parameters of LV function after RT.

Conclusions: Breast RT using contemporary techniques can be delivered without evidence of early subclinical LV dysfunction or injury as measured by echocardiography and hsTnI in patients treated with anthracyclines and trastuzumab. Future studies should focus on identifying alternative biomarkers to elucidate early RT-induced cardiovascular effects and further characterizing long-term cardiovascular outcomes associated with contemporary breast RT.

Keywords: Breast cancer; Cardiotoxicity; Radiation; Strain.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Time course of left ventricular ejection fraction (A), global longitudinal strain (B), global circumferential strain (C), and global radial strain (D) after breast radiatoin therapy. For LVEF, p < 0.05 for post-RT (*) compared to pre-RT. For GLS, GCS, and GRS, p > 0.05 for all post-RT and 6-month post-RT timepoints compared with pre-RT. Pre-RT, pre-radiation therapy; Post-RT, post-radiation therapy
Figure 1.
Figure 1.
Time course of left ventricular ejection fraction (A), global longitudinal strain (B), global circumferential strain (C), and global radial strain (D) after breast radiatoin therapy. For LVEF, p < 0.05 for post-RT (*) compared to pre-RT. For GLS, GCS, and GRS, p > 0.05 for all post-RT and 6-month post-RT timepoints compared with pre-RT. Pre-RT, pre-radiation therapy; Post-RT, post-radiation therapy
See this image and copyright information in PMC

References

    1. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116–26. - PubMed
    1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087–106. - PubMed
    1. Cheng YJ, Nie XY, Ji CC, Lin XX, Liu LJ, Chen XM et al. Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. Journal of the American Heart Association 2017;6. - PMC - PubMed
    1. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987–98. - PubMed
    1. Erven K, Jurcut R, Weltens C, Giusca S, Ector J, Wildiers H et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys 2011;79:1444–51. - PubMed

Publication types

MeSH terms